Best of AUA 2014: Basic Science Research

July 9, 2014

K.C. Balaji, MD, presents the take home messages on basic science research from the AUA annual meeting in Orlando, FL.

Click here for more Best of AUA 2014 coverage

• Copy number loss in NELL1 and a missense mutation linked to inflammation were identified in men with Peyronie’s disease, suggesting a genetic basis for this disease.

• Highly purified collagen coating showed promise for improving the biocompatibility of polypropylene mesh.

• Peripheral fatty acid amide hydrolase is a potential target for treating premature ejaculation.

• Immediate placement of a localized drug delivery system (sildenafil-loaded nanospheres) to the site of nerve injury improved erectile function in rats, suggesting potential application in patients undergoing radical prostatectomy.

• A combination of candidate genes (KISS1R, KISS1, CSAD, and SEPT9) could serve as prognostic markers for risk of primary bladder tumor metastasis.

• Compared to bacillus Calmette-Guérin (TheraCys, TICE BCG)-responsive tumors, high-grade nonmuscle-invasive bladder carcinomas that recur after BCG treatment have increased expression of genes implicated in cancer phenotype, including survival, migration, and invasion.

• Several studies identified miRNA signatures and various biomarkers as possible prognostic markers in renal cell carcinoma.

• Results in a mouse model suggest combination therapy of anti-CTLA4 antibody and anti-PD-1 antibody can be an option in kidney cancer.

• Induction of a hypometabolic state may be a useful strategy to reduce ischemic injury in renal surgery, results from a mouse model suggest.

• Thermotherapy with magnetic cationic liposomes suppressed bone metastasis in a novel rat model when administered with docetaxel (Taxotere).

• Differential expression of miRNAs in biopsies of patients with low-risk prostate cancer may identify patients at risk for upgrading.UT

Subscribe to Urology Times to get monthly news from the leading news source for urologists.